It's all about the topic of documentation in pharmaceutical industry. In this the specifications of pharmaceutical quality assurance plays the main role so that it's mainly effective for the people who is in the stream of pharmaceutical quality assurance.
This document discusses the batch manufacturing record (BMR) process for pharmaceutical companies. It provides details on:
- The responsibilities of quality assurance, production, and quality control in preparing, processing, reviewing, and approving BMRs.
- The documentation required in a BMR including equipment used, process parameters, batch details, packaging information, and analytical testing results.
- The standard operating procedures for issuing a BMR, documenting the batch production process, reviewing the completed BMR, and retaining records.
Premises - Part of Good Manufacturing PracticesTeny Thomas
This document discusses good manufacturing practices for pharmaceutical premises. It covers factors to consider for location, design, construction, sanitation, maintenance, utilities, and environmental control of premises to prevent contamination. The premises must have defined areas for receiving, sampling, storage, production, packaging, and quality control. Cleaning procedures and environmental monitoring programs are important to control contamination. Grade A or B areas for sterile products require additional controls like air quality standards and maintenance of sterile conditions.
Document Maintenance in Pharmaceutical IndustryNAKUL DHORE
Document Maintenance in Pharmaceutical Industry.
By_ NAKUL DHORE
❖ Introduction
❖ Batch Formula Record
❖ Master Formula Record
❖ SOPs
❖ Quality Audit
❖ Quality Review & Quality Documentation
❖ Reports & Documents
❖ Distribution Records
❖ MCQs
Quality Assurance
As per B.PHARM 3rd Year Semester-6
(PCI Syllabus New)
GOOD LABORATORY PRACTICES - A DETAILED STUDYTeny Thomas
A detailed study of the rules, regulations and guidelines of Good Laboratory Practices that should be practiced while conducting a Non Clinical Laboratory Study in Animals.
This document provides an overview of equipments and raw materials used in pharmaceutical manufacturing. It discusses the selection, purchase specifications, maintenance, and storage of both equipments and raw materials. Key points covered include cleaning and calibration of equipments, purchasing raw materials from approved vendors against specifications, and storing materials under proper conditions to prevent degradation.
Quality control on secondary packaging materialsAnupriyaNR
Presentation on quality control tests for the secondary packaging materials. Includes the materials used for secondary packaging, ideal properties of the secondary packaging material and various test procedures used for the quality control of the packaging materials.
This document outlines organization and personnel requirements for good manufacturing practices. It discusses that organizations must have sufficient qualified personnel to carry out tasks, with individual responsibilities clearly defined. Key personnel positions include the authorized person, head of production, and head of quality control. All personnel must receive training in GMPs initially and continuously. Personnel responsibilities include ensuring hygiene standards are followed.
This document discusses the batch manufacturing record (BMR) process for pharmaceutical companies. It provides details on:
- The responsibilities of quality assurance, production, and quality control in preparing, processing, reviewing, and approving BMRs.
- The documentation required in a BMR including equipment used, process parameters, batch details, packaging information, and analytical testing results.
- The standard operating procedures for issuing a BMR, documenting the batch production process, reviewing the completed BMR, and retaining records.
Premises - Part of Good Manufacturing PracticesTeny Thomas
This document discusses good manufacturing practices for pharmaceutical premises. It covers factors to consider for location, design, construction, sanitation, maintenance, utilities, and environmental control of premises to prevent contamination. The premises must have defined areas for receiving, sampling, storage, production, packaging, and quality control. Cleaning procedures and environmental monitoring programs are important to control contamination. Grade A or B areas for sterile products require additional controls like air quality standards and maintenance of sterile conditions.
Document Maintenance in Pharmaceutical IndustryNAKUL DHORE
Document Maintenance in Pharmaceutical Industry.
By_ NAKUL DHORE
❖ Introduction
❖ Batch Formula Record
❖ Master Formula Record
❖ SOPs
❖ Quality Audit
❖ Quality Review & Quality Documentation
❖ Reports & Documents
❖ Distribution Records
❖ MCQs
Quality Assurance
As per B.PHARM 3rd Year Semester-6
(PCI Syllabus New)
GOOD LABORATORY PRACTICES - A DETAILED STUDYTeny Thomas
A detailed study of the rules, regulations and guidelines of Good Laboratory Practices that should be practiced while conducting a Non Clinical Laboratory Study in Animals.
This document provides an overview of equipments and raw materials used in pharmaceutical manufacturing. It discusses the selection, purchase specifications, maintenance, and storage of both equipments and raw materials. Key points covered include cleaning and calibration of equipments, purchasing raw materials from approved vendors against specifications, and storing materials under proper conditions to prevent degradation.
Quality control on secondary packaging materialsAnupriyaNR
Presentation on quality control tests for the secondary packaging materials. Includes the materials used for secondary packaging, ideal properties of the secondary packaging material and various test procedures used for the quality control of the packaging materials.
This document outlines organization and personnel requirements for good manufacturing practices. It discusses that organizations must have sufficient qualified personnel to carry out tasks, with individual responsibilities clearly defined. Key personnel positions include the authorized person, head of production, and head of quality control. All personnel must receive training in GMPs initially and continuously. Personnel responsibilities include ensuring hygiene standards are followed.
The document discusses quality review, which involves reviewing all specifications and documentation at check points to ensure they are met. It outlines specific procedures to check, such as foreign matter, correct ingredients and amounts, separation of lots, storage conditions, cleaning, personnel readiness, and meeting specifications. Quality review also involves reviewing material, production, in-process, laboratory, and stability testing records using the 4M concept of material, method, machinery, and men.
This document outlines good warehouse practices for storage and distribution of pharmaceutical products. It discusses 12 key areas: premises, security, temperature and humidity control, equipment, personnel, sanitation, receipt of incoming goods, assembling orders and issuing goods, packing for transportation, transport, and records. The document provides details on requirements for each area to ensure proper storage conditions and distribution of medicines.
The document discusses Batch Manufacturing Records (BMR) and Master Formula Records (MFR) for pharmaceutical manufacturing. A BMR documents each batch production run and includes the batch number, materials used, production steps, yields, and test results. An MFR is the master document that provides the standard procedure for a product and is referenced when creating individual BMRs. It includes the product name, ingredients, batch size, packaging details, and authorization. Proper documentation with BMRs and MFRs is necessary for quality control and batch traceability in pharmaceutical manufacturing.
Purchase specifications & Maintenance of stores For Raw materialsYash Menghani
This document discusses the purchase specifications and maintenance of stores for raw materials. It defines raw materials as all materials used in manufacturing finished products. Purchase specifications provide guidelines that define operational, physical and chemical characteristics and quality of items to be acquired. Maintaining proper stores is important, requiring inspection centers, storage at appropriate temperatures, and clear labeling of materials with names, batch numbers, and expiration/retesting dates.
A COMPLETE STUDY ON COMPLAINTS, DRUG RECALL, RETURNED PRODUCTS, AND WASTE DIS...Teny Thomas
a detailed study on complaints, drug recall, returned goods and waste disposal is studied here in the presentation for the students of sixthe semester b.pharm following the PCI syllabus.
This document outlines personnel requirements according to Good Manufacturing Practices (GMP). It states that there must be enough qualified staff to carry out all manufacturing responsibilities. Key points include that each employee must have suitable education, training, and experience for their roles. Manufacturers must have an organization chart and clearly defined duties for positions like production head, quality assurance head, and quality control head. Training is also required for relevant staff. Personal hygiene programs tailored to different facility needs must be established and strictly followed.
COMPLAINTS
TOPIC COVERED
1.Definition
2.Principle
3.Need for complaint handling system
4.Objectives
5.Responsibility
6.Type of complaints (CRITICAL,MAJOR ,MINOR)
7.Key for handling complaint
8.Content of product complaint data sheet
9.Steps involved in handling of complaint
10.Recordings of complain
The document discusses product complaints and recalls in the pharmaceutical industry. It defines a complaint as customer dissatisfaction about a product and outlines four types of complaints. It details the four-step process of handling complaints, which includes receiving, investigating, implementing corrective actions, and reporting. The document also defines a recall as removing a product from distribution due to quality, safety or efficacy issues. It describes the reasons and types of recalls, as well as the classification, levels and timelines involved in an effective recall system.
This document provides guidelines on product recalls, including:
- Defining a product recall as withdrawing or removing drugs from distribution or use due to quality, efficacy, or safety issues.
- Describing the different types and levels of recalls, from compulsory recalls ordered by authorities to voluntary recalls initiated by manufacturers.
- Outlining the classification of recalls from Class I recalls for products that could cause serious health issues to Class III for minor issues.
- Providing steps for conducting an effective recall, including developing a recall strategy, recovering and storing products, notifying consumers, and evaluating the recall's effectiveness.
The document summarizes the key aspects of a Master Formula Record (MFR), including:
- The MFR is prepared by the R&D team and contains all information about the manufacturing process for a pharmaceutical product, including starting materials, packaging details, production steps, and quality checks.
- It serves as the reference standard for individual batch manufacturing records.
- The MFR includes detailed information like product name, active ingredients, batch size, equipment used, production steps, packaging process, theoretical and actual yields, and storage conditions.
- Preparing the MFR involves production and R&D teams and follows a standardized format and approval process.
This document provides an introduction to validation in the pharmaceutical industry. It discusses the origins and need for validation to ensure quality and control costs. The document outlines the key types of validation: prospective, retrospective, concurrent and revalidation. It also describes the scope of validation, noting it requires appropriate infrastructure, documentation, personnel and management involvement. Validation should be performed for facilities, equipment, utilities, processes and when major changes occur to demonstrate consistency in producing products that meet specifications.
This document outlines the process for handling pharmaceutical product complaints. It defines a complaint and discusses the need for proper complaint handling procedures. It classifies complaints as critical, major, or minor and describes the 4 main steps to handling complaints: receiving complaints, technical investigation, corrective and preventive actions/feedback, and trend analysis/reporting. Key aspects of each step like documentation, sampling, testing, reporting, and record keeping are described. Regulatory guidelines for complaint management are also provided.
QUALIFICATION OF UV-VISIBLE SPECTROPHOTOMETER, FTIR, DSC, HPLCAnupriyaNR
The document discusses the qualification and validation of various analytical techniques used in pharmaceutical quality control including UV-Visible spectrophotometry, Fourier-transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), and high performance liquid chromatography (HPLC). It provides details on the design qualifications, installation qualifications, operational qualifications, and performance qualifications required for each technique. The key steps include instrument calibration, determination of accuracy and precision, evaluation of limits, and verification that the instruments are operating as intended over time.
1. Returned goods and recovered materials from pharmaceutical products need to be evaluated and may be reprocessed, retested, repackaged and resold if they meet specifications.
2. Complaint handling procedures include classifying, investigating, reporting on complaints, maintaining records for regulatory compliance and continual improvement.
3. The complaint handling process involves receiving complaints, conducting a technical investigation which includes documentation review and laboratory analysis, determining corrective actions, and reporting trends to management.
Organization, personnels & premises in pharma industrieskirankumarsolanki3
This document discusses the requirements for personnel, premises, and key positions in quality manufacturing according to GMP guidelines. It states that personnel are the most important asset and their qualifications, training, hygiene and responsibilities must be in line with regulations. Key positions like production, quality control and assurance heads are defined along with their authorities and qualifications. Training procedures for induction and continuous development are also outlined. Premises must be designed and maintained to minimize risks of contamination and facilitate cleaning.
Regulations in India (ASU DTAB, ASU DCC), Regulation of
manufacture of ASU drugs - Schedule Z of Drugs & Cosmetics Act for ASU drugs.
Introduction
Regulatory Requirements
Key function of regulatory agencies
Regulation in India
DRUG TECHNICAL ADVISORY BOARD
Drugs Consultative committee-DCC
Schedule Z of Drugs & Cosmetics Act for ASU drugs.
Documentation in Pharmaceutical IndustryPooja Harkal
The document discusses technical documentation in the pharmaceutical industry. It describes key documents like the Master Formula Record (MFR), Batch Manufacturing Record (BMR), and Drug Master File (DMF). The MFR contains detailed product and process information and is used to prepare the BMR. The BMR records the entire manufacturing process for a specific batch and must be completed, reviewed, and approved. Proper documentation is essential in the pharmaceutical industry to ensure quality and compliance.
A Study on Documentation Maintenance in the Pharmaceutical Industry which includes the main records to be maintained and the quality attributes to be studied about the Quality Management System. Quality attributes include the study of quality audit, quality review, and quality documentation.
The document discusses quality review, which involves reviewing all specifications and documentation at check points to ensure they are met. It outlines specific procedures to check, such as foreign matter, correct ingredients and amounts, separation of lots, storage conditions, cleaning, personnel readiness, and meeting specifications. Quality review also involves reviewing material, production, in-process, laboratory, and stability testing records using the 4M concept of material, method, machinery, and men.
This document outlines good warehouse practices for storage and distribution of pharmaceutical products. It discusses 12 key areas: premises, security, temperature and humidity control, equipment, personnel, sanitation, receipt of incoming goods, assembling orders and issuing goods, packing for transportation, transport, and records. The document provides details on requirements for each area to ensure proper storage conditions and distribution of medicines.
The document discusses Batch Manufacturing Records (BMR) and Master Formula Records (MFR) for pharmaceutical manufacturing. A BMR documents each batch production run and includes the batch number, materials used, production steps, yields, and test results. An MFR is the master document that provides the standard procedure for a product and is referenced when creating individual BMRs. It includes the product name, ingredients, batch size, packaging details, and authorization. Proper documentation with BMRs and MFRs is necessary for quality control and batch traceability in pharmaceutical manufacturing.
Purchase specifications & Maintenance of stores For Raw materialsYash Menghani
This document discusses the purchase specifications and maintenance of stores for raw materials. It defines raw materials as all materials used in manufacturing finished products. Purchase specifications provide guidelines that define operational, physical and chemical characteristics and quality of items to be acquired. Maintaining proper stores is important, requiring inspection centers, storage at appropriate temperatures, and clear labeling of materials with names, batch numbers, and expiration/retesting dates.
A COMPLETE STUDY ON COMPLAINTS, DRUG RECALL, RETURNED PRODUCTS, AND WASTE DIS...Teny Thomas
a detailed study on complaints, drug recall, returned goods and waste disposal is studied here in the presentation for the students of sixthe semester b.pharm following the PCI syllabus.
This document outlines personnel requirements according to Good Manufacturing Practices (GMP). It states that there must be enough qualified staff to carry out all manufacturing responsibilities. Key points include that each employee must have suitable education, training, and experience for their roles. Manufacturers must have an organization chart and clearly defined duties for positions like production head, quality assurance head, and quality control head. Training is also required for relevant staff. Personal hygiene programs tailored to different facility needs must be established and strictly followed.
COMPLAINTS
TOPIC COVERED
1.Definition
2.Principle
3.Need for complaint handling system
4.Objectives
5.Responsibility
6.Type of complaints (CRITICAL,MAJOR ,MINOR)
7.Key for handling complaint
8.Content of product complaint data sheet
9.Steps involved in handling of complaint
10.Recordings of complain
The document discusses product complaints and recalls in the pharmaceutical industry. It defines a complaint as customer dissatisfaction about a product and outlines four types of complaints. It details the four-step process of handling complaints, which includes receiving, investigating, implementing corrective actions, and reporting. The document also defines a recall as removing a product from distribution due to quality, safety or efficacy issues. It describes the reasons and types of recalls, as well as the classification, levels and timelines involved in an effective recall system.
This document provides guidelines on product recalls, including:
- Defining a product recall as withdrawing or removing drugs from distribution or use due to quality, efficacy, or safety issues.
- Describing the different types and levels of recalls, from compulsory recalls ordered by authorities to voluntary recalls initiated by manufacturers.
- Outlining the classification of recalls from Class I recalls for products that could cause serious health issues to Class III for minor issues.
- Providing steps for conducting an effective recall, including developing a recall strategy, recovering and storing products, notifying consumers, and evaluating the recall's effectiveness.
The document summarizes the key aspects of a Master Formula Record (MFR), including:
- The MFR is prepared by the R&D team and contains all information about the manufacturing process for a pharmaceutical product, including starting materials, packaging details, production steps, and quality checks.
- It serves as the reference standard for individual batch manufacturing records.
- The MFR includes detailed information like product name, active ingredients, batch size, equipment used, production steps, packaging process, theoretical and actual yields, and storage conditions.
- Preparing the MFR involves production and R&D teams and follows a standardized format and approval process.
This document provides an introduction to validation in the pharmaceutical industry. It discusses the origins and need for validation to ensure quality and control costs. The document outlines the key types of validation: prospective, retrospective, concurrent and revalidation. It also describes the scope of validation, noting it requires appropriate infrastructure, documentation, personnel and management involvement. Validation should be performed for facilities, equipment, utilities, processes and when major changes occur to demonstrate consistency in producing products that meet specifications.
This document outlines the process for handling pharmaceutical product complaints. It defines a complaint and discusses the need for proper complaint handling procedures. It classifies complaints as critical, major, or minor and describes the 4 main steps to handling complaints: receiving complaints, technical investigation, corrective and preventive actions/feedback, and trend analysis/reporting. Key aspects of each step like documentation, sampling, testing, reporting, and record keeping are described. Regulatory guidelines for complaint management are also provided.
QUALIFICATION OF UV-VISIBLE SPECTROPHOTOMETER, FTIR, DSC, HPLCAnupriyaNR
The document discusses the qualification and validation of various analytical techniques used in pharmaceutical quality control including UV-Visible spectrophotometry, Fourier-transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), and high performance liquid chromatography (HPLC). It provides details on the design qualifications, installation qualifications, operational qualifications, and performance qualifications required for each technique. The key steps include instrument calibration, determination of accuracy and precision, evaluation of limits, and verification that the instruments are operating as intended over time.
1. Returned goods and recovered materials from pharmaceutical products need to be evaluated and may be reprocessed, retested, repackaged and resold if they meet specifications.
2. Complaint handling procedures include classifying, investigating, reporting on complaints, maintaining records for regulatory compliance and continual improvement.
3. The complaint handling process involves receiving complaints, conducting a technical investigation which includes documentation review and laboratory analysis, determining corrective actions, and reporting trends to management.
Organization, personnels & premises in pharma industrieskirankumarsolanki3
This document discusses the requirements for personnel, premises, and key positions in quality manufacturing according to GMP guidelines. It states that personnel are the most important asset and their qualifications, training, hygiene and responsibilities must be in line with regulations. Key positions like production, quality control and assurance heads are defined along with their authorities and qualifications. Training procedures for induction and continuous development are also outlined. Premises must be designed and maintained to minimize risks of contamination and facilitate cleaning.
Regulations in India (ASU DTAB, ASU DCC), Regulation of
manufacture of ASU drugs - Schedule Z of Drugs & Cosmetics Act for ASU drugs.
Introduction
Regulatory Requirements
Key function of regulatory agencies
Regulation in India
DRUG TECHNICAL ADVISORY BOARD
Drugs Consultative committee-DCC
Schedule Z of Drugs & Cosmetics Act for ASU drugs.
Documentation in Pharmaceutical IndustryPooja Harkal
The document discusses technical documentation in the pharmaceutical industry. It describes key documents like the Master Formula Record (MFR), Batch Manufacturing Record (BMR), and Drug Master File (DMF). The MFR contains detailed product and process information and is used to prepare the BMR. The BMR records the entire manufacturing process for a specific batch and must be completed, reviewed, and approved. Proper documentation is essential in the pharmaceutical industry to ensure quality and compliance.
A Study on Documentation Maintenance in the Pharmaceutical Industry which includes the main records to be maintained and the quality attributes to be studied about the Quality Management System. Quality attributes include the study of quality audit, quality review, and quality documentation.
The document discusses batch manufacturing records (BMRs) and master formula records (MFRs) for pharmaceutical products. It notes that BMRs should include complete information about manufacturing and quality control for each batch, and that line clearance is important before starting a new batch to ensure all remnants of the previous batch are removed. MFRs should provide detailed instructions for each product and batch size. Both BMRs and MFRs are important quality documentation that allow for full traceability of the manufacturing process.
The document provides details on Master Formula Records (MFRs), including that MFRs:
- Are master documents that contain all information about manufacturing a pharmaceutical product, including ingredients, quantities, processes, and quality checks.
- Are prepared by the research and development team and used as a reference for batch manufacturing.
- Include product details, manufacturing processes, packaging processes, calculations, and quality approval by production and quality assurance heads.
MFRs ensure consistency in production and provide standards for Batch Manufacturing Records. Comprehensive information in MFRs allows for accurate reproduction of manufacturing batches.
The document discusses Batch formula record and Master Formula record. A Master formula record specifies starting materials, quantities, packaging materials and processing instructions for producing a specific quantity of a finished product. It includes production location, equipment used, storage instructions, expected yields and quality checks. A Batch manufacturing record documents the actual production of a batch, including all stages from raw materials to finished product. It contains processing details, yields, test results and any deviations for batch traceability and regulatory compliance.
The document discusses batch records, standard operating procedures, quality audits, and related quality control processes in pharmaceutical manufacturing. It defines a batch record as a written document containing production and quality control data for each batch. It also describes what information should be included in batch processing records, packaging records, and batch manufacturing records. The document outlines guidelines for developing standard operating procedures and the benefits of implementing SOPs. It differentiates between internal audits conducted within a company and external audits of suppliers, noting the aims and typical steps of each type of quality audit.
Documentation control - principles of GMPAJAYKUMAR4872
Documentation is an essential part of QA and relates to all aspects of GMP.
The pharmaceutical industry must have a good document framework (infrastructure).
It is important for a manufacturer to get the documentation right in order to get the product right.
The document discusses the Master Formula Record (MFR), which contains all information about the manufacturing process for a pharmaceutical product. It is prepared by the research and development team and used as a reference standard for preparing batch manufacturing records. The MFR includes details like product name, ingredients, batch size, manufacturing process steps, packaging process, and expected yields. It provides standardized instructions for consistently producing batches of a product.
Unit 4 Document maintenance in Pharmaceutical Industry.pptxAshwiniBhoir2
The document discusses the importance of documentation in the pharmaceutical industry. It states that documentation provides evidence of activities and ensures quality assurance. Good documentation includes specifications, procedures, and information to ensure manufacturing processes are followed correctly. It also discusses the types of documents needed like batch production records, master formulas, standard operating procedures, distribution records, and emphasizes that documents must be properly designed, approved, distributed and updated to ensure compliance.
Master Formula Record (MFR) is a master document for any
pharmaceutical product. MFR contains all information about the manufacturing process
for the product. MFR is prepared by the research and development team of the
company. MFR is used as reference standard for preparing batch manufacturing record (BMR) by manufacturing units.
documentation in pharmaceutical industry ppt.pptxashokgorja8
To define specifications and procedures for all materials and method of manufactured and control.
To ensure that all personal concern with manufacture know what to do and when to do it.
documentation in pharmaceutical industry ppt.pptxashokgorja8
The document discusses documentation requirements in the pharmaceutical industry. It defines documentation and explains that documentation is an integral part of good manufacturing practices (GMP). It describes the objectives of documentation such as defining specifications and procedures. It provides details about types of documentation required by GMP such as master formula records, batch manufacturing records, distribution records, specifications, and quality auditing. The document emphasizes that comprehensive documentation is necessary to ensure product quality and traceability in the pharmaceutical industry.
pratik ghive cGMP According to schedule Mpratikghive82
Pratik Ghive Current Good Manufacturing Practices (cGMP) Guidelines According to schedule M Cover all guidelines as per Drug and cosmetic act 1940 and ICH guidelines
This document discusses pilot plant scale up techniques. It defines a pilot plant as transforming a lab scale formula into a viable product through practical manufacturing procedures. The objectives of pilot plant studies are to examine a formula's ability to withstand scale changes and identify critical process features before committing to full production. Key steps include defining rate-controlling steps, designing and constructing a pilot plant, evaluating results, and making corrections before full-scale development. General considerations are also outlined, such as personnel requirements, equipment, production rates, and process evaluation.
Documentation with respect to release of finished pharmaceutical productMadhuraNewrekar
Documentation is a crucial part of the quality assurance system and is needed in every aspect of pharmaceutical manufacturing. Important documentation with respect to final product release in pharmaceutical industry is explained in brief.
Documentation is an essential part of good manufacturing practices in the pharmaceutical industry. Key aspects of documentation include master production records, batch records, material identification systems, laboratory records, distribution records, and complaint files. Documentation provides a complete history of each batch and helps ensure quality, traceability, and compliance with specifications and procedures. It also enables investigation of any issues that may arise.
Technology Transfer and Scale-up in Pharmaceutical IndustryPranjalWagh1
Transfer of technology is defined as “a logical procedure that controls the transfer of any process together with its documentation and professional expertise between development and manufacture or between manufacture sites”.
In Pharmaceutical Industry, technology transfer refers to the processes that are needed for successful progress from drug discovery to product development to clinical trials to full scale commercialization.
It is basically divided into three phases - Research Phase, Development Phase and Production Phase. The presentation elaborates on the technology transfer taking place in production phase. Production phase mainly concerns with validation studies and scale-up.
Validation studies such as performance qualification, cleaning validation and process validation is carried out by R&D department.
Scale-up involves the use of results obtained from lab studies for designing prototype of a product and pilot plant process, constructing pilot plant and further using pilot plant data for full-scale commercialization.
This document discusses the space requirements and considerations for designing a pharmaceutical pilot plant facility. It outlines that the facility should have separate areas for administration, physical testing, standard equipment, and storage. The standard equipment area should contain portable intermediate and full-scale production equipment for evaluating scale-up effects. The document also discusses raw material approval and validation, master batch records, analytical method transfer, product stability testing, and GMP compliance considerations like equipment qualification and validation.
The document discusses documentation processes in organizations. It explains that documentation involves systematically recording people, events, and documents to create organizational records. Documentation provides information on how to complete tasks as well as evidence that tasks were done correctly. Master formula records (MFRs) are important documentation that contain all information about a pharmaceutical product's manufacturing process. MFRs are prepared by research teams and used as a reference for batch manufacturing records. The document outlines the key components that should be included in MFRs and batch manufacturing records to ensure consistency in manufacturing batches. It also discusses standard operating procedures and importance of documentation policies in organizations.
Ähnlich wie Documentation in pharmaceutical industry (20)
How to Make a Field Mandatory in Odoo 17Celine George
In Odoo, making a field required can be done through both Python code and XML views. When you set the required attribute to True in Python code, it makes the field required across all views where it's used. Conversely, when you set the required attribute in XML views, it makes the field required only in the context of that particular view.
Chapter wise All Notes of First year Basic Civil Engineering.pptxDenish Jangid
Chapter wise All Notes of First year Basic Civil Engineering
Syllabus
Chapter-1
Introduction to objective, scope and outcome the subject
Chapter 2
Introduction: Scope and Specialization of Civil Engineering, Role of civil Engineer in Society, Impact of infrastructural development on economy of country.
Chapter 3
Surveying: Object Principles & Types of Surveying; Site Plans, Plans & Maps; Scales & Unit of different Measurements.
Linear Measurements: Instruments used. Linear Measurement by Tape, Ranging out Survey Lines and overcoming Obstructions; Measurements on sloping ground; Tape corrections, conventional symbols. Angular Measurements: Instruments used; Introduction to Compass Surveying, Bearings and Longitude & Latitude of a Line, Introduction to total station.
Levelling: Instrument used Object of levelling, Methods of levelling in brief, and Contour maps.
Chapter 4
Buildings: Selection of site for Buildings, Layout of Building Plan, Types of buildings, Plinth area, carpet area, floor space index, Introduction to building byelaws, concept of sun light & ventilation. Components of Buildings & their functions, Basic concept of R.C.C., Introduction to types of foundation
Chapter 5
Transportation: Introduction to Transportation Engineering; Traffic and Road Safety: Types and Characteristics of Various Modes of Transportation; Various Road Traffic Signs, Causes of Accidents and Road Safety Measures.
Chapter 6
Environmental Engineering: Environmental Pollution, Environmental Acts and Regulations, Functional Concepts of Ecology, Basics of Species, Biodiversity, Ecosystem, Hydrological Cycle; Chemical Cycles: Carbon, Nitrogen & Phosphorus; Energy Flow in Ecosystems.
Water Pollution: Water Quality standards, Introduction to Treatment & Disposal of Waste Water. Reuse and Saving of Water, Rain Water Harvesting. Solid Waste Management: Classification of Solid Waste, Collection, Transportation and Disposal of Solid. Recycling of Solid Waste: Energy Recovery, Sanitary Landfill, On-Site Sanitation. Air & Noise Pollution: Primary and Secondary air pollutants, Harmful effects of Air Pollution, Control of Air Pollution. . Noise Pollution Harmful Effects of noise pollution, control of noise pollution, Global warming & Climate Change, Ozone depletion, Greenhouse effect
Text Books:
1. Palancharmy, Basic Civil Engineering, McGraw Hill publishers.
2. Satheesh Gopi, Basic Civil Engineering, Pearson Publishers.
3. Ketki Rangwala Dalal, Essentials of Civil Engineering, Charotar Publishing House.
4. BCP, Surveying volume 1
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...PECB
Denis is a dynamic and results-driven Chief Information Officer (CIO) with a distinguished career spanning information systems analysis and technical project management. With a proven track record of spearheading the design and delivery of cutting-edge Information Management solutions, he has consistently elevated business operations, streamlined reporting functions, and maximized process efficiency.
Certified as an ISO/IEC 27001: Information Security Management Systems (ISMS) Lead Implementer, Data Protection Officer, and Cyber Risks Analyst, Denis brings a heightened focus on data security, privacy, and cyber resilience to every endeavor.
His expertise extends across a diverse spectrum of reporting, database, and web development applications, underpinned by an exceptional grasp of data storage and virtualization technologies. His proficiency in application testing, database administration, and data cleansing ensures seamless execution of complex projects.
What sets Denis apart is his comprehensive understanding of Business and Systems Analysis technologies, honed through involvement in all phases of the Software Development Lifecycle (SDLC). From meticulous requirements gathering to precise analysis, innovative design, rigorous development, thorough testing, and successful implementation, he has consistently delivered exceptional results.
Throughout his career, he has taken on multifaceted roles, from leading technical project management teams to owning solutions that drive operational excellence. His conscientious and proactive approach is unwavering, whether he is working independently or collaboratively within a team. His ability to connect with colleagues on a personal level underscores his commitment to fostering a harmonious and productive workplace environment.
Date: May 29, 2024
Tags: Information Security, ISO/IEC 27001, ISO/IEC 42001, Artificial Intelligence, GDPR
-------------------------------------------------------------------------------
Find out more about ISO training and certification services
Training: ISO/IEC 27001 Information Security Management System - EN | PECB
ISO/IEC 42001 Artificial Intelligence Management System - EN | PECB
General Data Protection Regulation (GDPR) - Training Courses - EN | PECB
Webinars: https://pecb.com/webinars
Article: https://pecb.com/article
-------------------------------------------------------------------------------
For more information about PECB:
Website: https://pecb.com/
LinkedIn: https://www.linkedin.com/company/pecb/
Facebook: https://www.facebook.com/PECBInternational/
Slideshare: http://www.slideshare.net/PECBCERTIFICATION
Leveraging Generative AI to Drive Nonprofit InnovationTechSoup
In this webinar, participants learned how to utilize Generative AI to streamline operations and elevate member engagement. Amazon Web Service experts provided a customer specific use cases and dived into low/no-code tools that are quick and easy to deploy through Amazon Web Service (AWS.)
Walmart Business+ and Spark Good for Nonprofits.pdfTechSoup
"Learn about all the ways Walmart supports nonprofit organizations.
You will hear from Liz Willett, the Head of Nonprofits, and hear about what Walmart is doing to help nonprofits, including Walmart Business and Spark Good. Walmart Business+ is a new offer for nonprofits that offers discounts and also streamlines nonprofits order and expense tracking, saving time and money.
The webinar may also give some examples on how nonprofits can best leverage Walmart Business+.
The event will cover the following::
Walmart Business + (https://business.walmart.com/plus) is a new shopping experience for nonprofits, schools, and local business customers that connects an exclusive online shopping experience to stores. Benefits include free delivery and shipping, a 'Spend Analytics” feature, special discounts, deals and tax-exempt shopping.
Special TechSoup offer for a free 180 days membership, and up to $150 in discounts on eligible orders.
Spark Good (walmart.com/sparkgood) is a charitable platform that enables nonprofits to receive donations directly from customers and associates.
Answers about how you can do more with Walmart!"
How to Manage Your Lost Opportunities in Odoo 17 CRMCeline George
Odoo 17 CRM allows us to track why we lose sales opportunities with "Lost Reasons." This helps analyze our sales process and identify areas for improvement. Here's how to configure lost reasons in Odoo 17 CRM
বাংলাদেশের অর্থনৈতিক সমীক্ষা ২০২৪ [Bangladesh Economic Review 2024 Bangla.pdf] কম্পিউটার , ট্যাব ও স্মার্ট ফোন ভার্সন সহ সম্পূর্ণ বাংলা ই-বুক বা pdf বই " সুচিপত্র ...বুকমার্ক মেনু 🔖 ও হাইপার লিংক মেনু 📝👆 যুক্ত ..
আমাদের সবার জন্য খুব খুব গুরুত্বপূর্ণ একটি বই ..বিসিএস, ব্যাংক, ইউনিভার্সিটি ভর্তি ও যে কোন প্রতিযোগিতা মূলক পরীক্ষার জন্য এর খুব ইম্পরট্যান্ট একটি বিষয় ...তাছাড়া বাংলাদেশের সাম্প্রতিক যে কোন ডাটা বা তথ্য এই বইতে পাবেন ...
তাই একজন নাগরিক হিসাবে এই তথ্য গুলো আপনার জানা প্রয়োজন ...।
বিসিএস ও ব্যাংক এর লিখিত পরীক্ষা ...+এছাড়া মাধ্যমিক ও উচ্চমাধ্যমিকের স্টুডেন্টদের জন্য অনেক কাজে আসবে ...
A review of the growth of the Israel Genealogy Research Association Database Collection for the last 12 months. Our collection is now passed the 3 million mark and still growing. See which archives have contributed the most. See the different types of records we have, and which years have had records added. You can also see what we have for the future.
1. UNIVERSITY OF CHEMICAL TECHNOLOGY,
CHHATRAPATI SAMBHAJINAGAR.
PHARMACEUTICAL QUALITY ASSURANCE DEPARTMENT
~ POOJA HARKAL
Documentation in Pharmaceutical Industry
2. Technical Documentation
Documentation is the Essential and crucial part in any of the company. In pharma we
can say “If it is not documented, it has not done”. Documentation is an evidence to
show or to prove that the things have done accordingly. Quality assurance documents
are the heart of the company.
Technical documents are
Master Formula Record (MFR).
Batch Manufacturing Record (BMR).
Drug Master File (DMF)
While registering the Indian product in overseas market RA team should be carefully
check, verify all the documents for the genuinity, quality and uniformity from batch
to batch and to avoid delay in the approval process.
4. Master Formula Record (MFR):
MFR is a master document which contains detailed
information about the product, process etc. MFR is
prepared by the Formulation and Development team
which is called technology transfer. By this master
document BMR and BPR prepared.
5. MASTER BATCH RECORD
1. Master Batch Record also known as MFR (Master Formula/Mfg Record).
2. It should be available for each product, batch and pack size.
3. It is a master document for any pharmaceutical product.
4. It contains all information about the manufacturing process for the product.
5. It is prepared by the research and development team of the company.
6. It is used as reference standard for preparing batch manufacturing record
(BMR) by manufacturing units.
7. It plays an important in consistency for each batch manufacturing.
Responsible Department :
Primary Responsibility : Formulation Research and Production Department
Secondary Responsibility : QA Department
6. Content
of Master
Batch
Record
1. Product details:
Name, address, logo of the manufacturing
company.
Product name.
Dosage form.
Brand name.
Generic name.
Product code.
Product description.
Label claim of all ingredients used. Batch size.
Pack size.
Shelf life.
Storage conditions
7. 2. Flow chart:
• Steps involved in the manufacturing process and flow chart representing the
material movement from dispensing to the finished product to packaging and to
the store.
3. Equipment:
• List of equipment required for the manufacture of the product with the capacity
4. Special instructions:
• Warnings and precautions related to manufacturing process should be clearly
mentioned.
• Quantity to be added should be mentioned.
• Time interval and overages to be added to be mentioned clearly.
• Name of the ingredient with tests and specification limit as per IP, BP and USP.
5. Calculations:
• Quantity to be added to get 100% final product.
• It can be done by using water content or LOD to get 100% potency.
8. 6. Manufacturing process:
It should include all the steps involved the manufacturing
process like sifting, milling, granulation, mixing, blending,
lubricating, compression, coating, filling, if necessary filtration
with environmental conditions such as temperature, humidity,
storage to be maintained with time.
7. Packaging process:
Details of packaging materials used.
Line clearance, batch reconciliation of the packing
material.
8. Yield:
It includes theoretical yield, Practical yield and acceptance
limit of the batch
9.
10. Master Batch Record Packaging details :
• There have to be authorized packaging instructions
• Name.
• Description of dosage form.
• Pack sizes- Number, dose volume.
• A total list of all Packaging materials required for standard
batch size with reference to the specifications of the packaging
material
• Specimens of all packaging material.
• Line clearance instructions.
• Description of packaging operations.
• In process controls.
11. BATCH MANUFACTURING RECORD
Once the Master formula is prepared, pilot batch will be started to
validation and BA/BE studies, upon getting the report from the pilot batch
BMR will be prepared which will be used for commercial batch
manufacturing.
a. The "Batch Manufacturing Record" is the necessary quality and GMP documentation for
tracing the complete cycle of manufacturing batch or lot.
b. The batch manufacturing record should be checked before issuance to assure that it is the
correct version and a legible accurate reproduction of the appropriate master production
instruction.
c. Before any processing begins, a check should be performed and recorded to ensure that the
equipment and workstation are clear of previous products, documents, or materials not
required for the planned equipment is clean and suitable for use.
d. These records should be numbered with a unique batch or identification number and dated
and signed when issued.
12. Batch Manufacturing Record Content :
1. Name of the product, Batch number, revision number, effective
date.
2. Product details like Type of the product, dosage, shape of the drug.
3. Batch size and Total number of tablets or capsules.
4. Pack size and packaging Instructions.
5. Storage instructions.
6. Production batch record issuance.
7. Signed & issued by QA
8. Signed for completion by production
9. Bill of materials: It is a list of all raw material ingredients that are
required involving more materials appear in the final product.
13. 10.Reference documents i.e., SOP’s such as Dispensing of the product,
temperature and humidity monitoring, material weighing, cleaning procedure,
use, operation and cleaning of the equipment.
11.List of raw material along with quantity required.
12.Equipment description, calibration certificate etc.
13.Area clearance- step by step cleaning of the equipment and area.
14.Production procedure- Instruction for each step of the production from
dispensing to dispatch.
15. Calculation of yield.
Yield =Weight of tablets × 100
Weight of raw materials
Finished product Yield = No. of goods produced in process+Rejects+Samples+Returned × 100
No. of goods received at the start of procedure
14. 16. Post production review- Complete batch has been reviewed for
the completeness and accuracy in the entries for Good
Documentation Practices.
17. Product release- the product should comply with the finished
goods specifications and released to market
Responsibility :
• Primary Responsibility : QA/ QC/ Production Officer
• Secondary Responsibility : QA/ QC/ Production Manager
15. BMR format should contain following parts:
1. Batch record : First page of the BMR has all records about the batch as batch no.,
batch size, composition MFR, weight of drug, shelf life, storage condition,
manufacturing date, expiry date.
2. General instruction for mfg. : Health and safety instruction to the operation and
be followed during the mfg. process regarding the material and equipment used
during mfg.
3. Equipment cleaning record : Check list of the cleaning of all equipment is
prepared. Those are used in manufacturing of the batch including the previous
product batch and date of cleaning.
4. Bills of materials : list of the raw materials should have the quantity of the material
with that AR number. Weight of the material should be verified by QA.
16. 5. Manufacturing Process : Should be written step by step in easy language.
Milling, Shifting, Drying, Compression, Coating and Packing having all
instruction with process time should be written.
6. Yield : Yield of batch should be calculated at the end of every stage to
calculate the process loss. Final yield should be calculated at the end of
manufacturing that should not be less than 99%.
7. Abbreviations : list of used in document should be made to understand the
BMR easily.
8. History of changes : At the end of document should have a list of the
changes in the document including the revision no. and date of change.
17.
18. Documentation of Completion of each Significant step in
the BMR should include:
• Specific identification of each batch, including weights, measures,
and batch numbers of raw materials, intermediates, or any
reprocessed materials used during manufacturing.
• Signatures of the persons performing and directly supervising or
checking each critical step in the operation.
19. • In-process and laboratory test results.
• Actual yield at appropriate phases or times.
• Any deviation noted, its evaluation, and investigation conducted (if
appropriate) or reference to that investigation (if stored separately).
• Results of release testing.
• Production and quality control records should be reviewed as part of
the approval process of batch release.
• Any divergence or failure of a batch to meet its specifications should be
thoroughly investigated.
20. Following Attachments Required To Be Attached To BMR Before
Submitting The Completed BMR To Quality Assurance :
Equipment clean record status label.
Equipment clean record.
Raw materials dispensed weighing slip.
Intermediate raw material sealed.
Transfer note for finished goods to F.G. store.
Raw material issue order (P.R).
IPQC-In Process Test Request Cum Report.
Excess material requisition (S.R.).
Deviation note if any.
Certificate of Analysis (COA).
Finish product dispatched data.
21. CONCLUSION
• Master batch records provide the product's overall description
and detailed manufacturing and testing instructions.
• Batch manufacturing record (BMR) is an important document for
chemical and process manufacturers.
• It tells users how to produce a batch of a given product, then
records the entire production process, from start to finish.
• It is a complete specification for manufacturing a specific batch
size in a specific plant at a specific time.
22. Introduction Of Quality Audit :
Quality audit Is defined as a
“Systematic and independent
examination of manufacturer
quality system to determine
whether activities and related
results comply with planned
arrangement are implemented
effectively and we suitable to
achieve objective.”
Quality audit means a
systematic examination
of a quality system.
Quality audits are
typically performed at
defined intervals.
Any failure in their proper
implementation may be
published publicly and may
lead to a revocation of
quality certification.
23. • To check out the compliances of activities and results of
quality systems; with the procedures of quality systems.
• To investigate that whether the working procedures are
implemented effectively or not.
• Also to evaluate that implemented procedures are suitable or
not, in order to achieve the objectives of quality systems.
• Basically this quality audit is carried out by internal / external
quality auditors or audit team.
• This quality audit programs are effective means of evaluating
the compliance with the objectives of quality system.
• Also it provides the feedback to the management, as a part of
continuous improvement program.
• We can also evaluate the particular process or activity,
whether it is going as per plan or not. And if any deviation is
occurring then corrective action can be taken to bring the
process on normal.
Objectives
Of Quality
Audit
Planning:
24. Aims
of
quality
audit
plan:
To access the company's performance on the fact.
To obtained unbiased information about company.
To know factually if company is at risk.
To evaluate manufacturers compliance with GMP.
To identify the deficiency and faults to make improvements in quality.
To investigate the root cause of any quality related problem.
To educate and trained the people within organization.
To make the supplier aware of any quality related problem in their supplies.
25. Internal
Audit
External
Audit
Regulatory
Audit
Types
of
Audit :
The other names of this type of audit are first party audit or self audit.
The auditors and the process or product being audited belongs to same company.
Self audit helps to achieve goals of pharmaceutical industry in a professional
way by advising them in improvement of any procedure related to the
quality of the product.
1.Internal audit
26. BENEFITS OF INTERNALAUDIT :
Tells you the health of a quality system.
Identify the root of a problem and plan for corrective and
preventive actions with timeline.
Achieve better allocation of resources.
Able to avoid potentially big problem
continuous improvement.
27. 2.EXTERNALAUDIT
The another name of this audit is known as Second Party Audit.
These audits are usually carried out for any outsourcing operations or
suppliers.
This is the reason in this audit customer is actually performing audit on
supplier or contractor.
The organization has to comply may rules and regulations eg. cGMP
guidelines and thus audits of the contractors and suppliers is also having
important role in regulatory compliance.
Third party
A customer wants an audit of your company but wants your
company to pay for it.
28. 3.
Regulatory
Audit
These audits are carried out by regulatory bodies against relevant regulations for the
manufacture and supply of pharmaceutical products.
National regulatory bodies, such as the Medicines Control Agency (MCA) in the UK
and Food And Drug Administration (FDA) in the USA, are statutorily responsible for
carrying out such audits.
These audits may be unannounced (MCA currently performs about ten percent of
its UK inspections like this) as manufacturers are expected to be complying with
GMP at all times.
Regulatory bodies from other countries in which products are sold may also audit
companies (i.e. FDAAudits European Manufacturers).
Regulatory inspectors are extensively trained and are knowledgeable and
professional.
Failure to pass a regulatory audit can lead practical experience of GMP and receive to
restrictions on (or the withdrawal ) of a manufacturing or import/export license.
29.
30. Plan and prepare
Arrange and
announce
Arrive at the site
meet and explain
purpose
Perform audit
Informal oral
report of finding
Formal report
with
recommendations
Follow up
31. AUDIT PLANNING:
Before
Audit
During
Audit
After
Audit
1. Before Audit
• Plan well in advance.
• Decide if there are any products or activites that you
want to exclude from the audit.
• Know your procedures and where they are located.
• Remove all absolute documentation.
• Ensure all uncontrolled documentation that you are
working with are properly stamped "uncontrolled“.
• Label all your filing cabinets and files.
• Ensures all productive material, is identified by
number and status.
• Ensure all materials are stored in authorized areas.
32. • Eliminate all unused ,scrap/suspect material from around machine and workstations.
• Scrap /non-confirming material must be segregated and clearly identified.
• Do not over communicate and make people nervous, the system is being tested not them.
• Be prepared for the audit team to spelt up and audit separately.
• Have an audit communication center set up.
DURING AUDIT
Make everyone aware that the auditors are likely to ask up to six questions:
1. What is your quality policy.
2. Tell me how do you do your job.
3. Show me where your system it tells you to do this.
4. Can i see some evidences.
5. What action do you take if you have problems.
6. What training have you received to help you to do this job.
33. Be punctual and respectful .
Be honest in your answers.
Do not brag: they are not customer. You do not have to impress them with the past
or future, just what happens now.
Do not volunteer additional information. Just answer the question asked and stop.
Do not “ramble on”.
Do not use terms like “usually” or “generally”. They invite further questions.
Do not fill in space between questions. If there is a gap, let the auditor fill it.
Do not rush or divert the auditors. They are responsible for their own schedule.
Note any non-compliances observed in as much detail as possible.
Do not “point fingers” at someone else in front of the auditors.
Do not challenge or argue to excess. Make your point then stop.
Do not be panic.
34. AFTER AUDIT
• Do not argue at the exist meeting.it is too late.
• Do not rush into hasty corrective action-do it
properly.
• Remain polite, even if you did not do well-it is not
the auditor fault; it is your organization that failed.
35. Report the successful Audit can be achieved through a formal
report that has been generated by the leader of the Audit Team
and reviewed by that individual's manager the essential
elements of the audit report should include
1. Distribution List.
2. Dates Of Audit.
3. Scope Of Audit.
4. Name Of Team Leader.
5. Name Of Other Team Members With Positions In Team Eg.
Auditor, Expert, Auditor In Training, Guest And So On.
AUDIT REPORT
36. 6. Standards of reference used in audit.
7. Date of opening meeting with list of attendees and position
titles.
8. Date of closing meeting with list of attendees and position title.
9. General strengths.
10. General weakness.
11. Specific observations requiring corrective and or preventive
actions.
12. Request for corrective and preventive action plans for each
observation.
13. Due date for the response to the audit report.
37. 14.Information of audit report is highly confidential therefore copies of the audit
report should be controlled.
15.Many companies use unique codes or numbering methods to control the
copies.
16.It is necessary to follow and track the corrective and preventive actions.
17.Audit is not really completely closed out until all observations have been
verified as effectively corrected.
18.Monitoring of effectiveness may take very long time (a year or more) some
auditors elect to close out the audit once the corrective and preventive actions
have been verified correctly.
38.
39. Introduction of Distribution Record
Distribution record are written data related to distribution of drug
product from the manufacturer to the distributor.
It include wide range of document like invoice bill of lading,
customer receipt’s, internal warehouse storage and inventory record
it etc.
Maintenance of records is important to facilitate complete recall of
batch, if necessary.
40. DISTRIBUTION RECORDS
The distribution record should be contain:
a. Name ,strength of the product, distribution of the doses form.
b. Name an address of the consignee.
c. Data and quantity shipped and lot of control number of the drug
product.
d. The distribution record shall we maintain in a manner.
e. So as to facilitate prompt and complete recall of the batch if necessary.
f. Prior to distribution or dispatch of batch of a drug it should be insure
that the batch has been tested, approved and release by quality control
personnel.
41. DISTRIBUTION PROCEDURE
Written procedure shall be established and followed, describe in
the distribution of drug products.
A procedure where by the oldest approved stock and product is
distribution first.
A system by which the distribution of each lot of drug product
can be the readily determine to facilitate it’s recall if necessary.
Distribution record must be constructed and procedure
established to facillate recall of defective product.
Manufacturer must maintain record of the distribution
transaction involving in the process of finishing goods.
42. All record should be indexed by either manufacturing batch
number of the packaging control number as the mean of
accountability until the shipment passes from the direct control of
manufacturer.
The distribution process also include other consideration it must
be arrange so that a first in /first out of moment of product occur.
APIs should only the release for distribution to third party after
they have the been released by the quality unit.
API should be transported in the manner that does not adversely
affect their quality.
A system should be in place by which the distribution of each
batch of intermediate and API can be readily determine to permit
its recall.
43. ELECTRONIC DATA HANDLING:
According to 21 CFR part 11 the electronic record can be
electronics signature must control the electronic data record
security, integrity, traceability and the proper use of
electronics signature.
A document management system consists of hardware and
software that convert paper document into the electronic
documents, manages and achieve those electronic
document and they index and store them according to
company policy.
44. Objective for the implementing and EDC
system in clinical trial
1. Real time data access.
2. Efficient data transfer and faster impact on marketing
of drug.
3. Overcoming the shipping of paper CRFs (case report
form) from remote areas.
4. Synergy between the serious adverse effect reporting
and the data base.
45. ADVANTAGES
Faster data
transfer.
Instant
data
access by
the staff.
Reduced
queries.
Installation of
software in each
PC which is
costlier.
Availability of
internet
connection is
remote where
trial is being
conduct.
Data security is
a major problem
if public internet
is being used.
DISADVANTAGES
46. CONTROLLED DOCUMENT UNCONTROLLED DOCUMENT
Documents shall be periodically reviewed
(recommended once/year).
QA & Document control Centre are
responsible to ensure that issued documents
are controlled, effective and implemented.
Use of electronic signatures as well as
electronic maintenance and submission, is
an acceptable substitution for paper, when
practical.
Documents that is not subjected to
amendments, changes or revisions and
not traceable.
OR
The photocopy of master copy of
controlled documents or written
procedure which shall be given to any
department or person for reference
purpose only.
47. Drug Master File (DMF)
DMF is a confidential document for API (Active Pharmaceutical Ingredient)
submitted to the regulatory body for the approval process.
In fact there is no regulations to file a DMF.
It is not reviewed on receipt as like dossier and DMF’s are neither approved
nor disapproved.
It has
divided into
2 parts
• Open part (Applicant’s Part): Contains all the required information
related to method of manufacture and brief outline of method of
manufacture, potential impurities, manufacturing system etc.
• Closed Part (Restricted Part): Contains Confidential information on the
manufacture of API like Extraction, validation, process, solvents approved.
It has divided into 2 parts used, reactions, temperature, conditions, critical
steps in manufacture etc.
48. Apart from this DMF is divided into 5 types
Type I: Plant information (No more a part of
DMF)
Type II: Drug substance, drug products,
intermediates and materials used in
manufacturing.
Type III: Packaging materials.
Type IV: Excipients or additives.
Type V: FDA accepted reference information
49. Type I DMF
It contains information about the plant
information like
Manufacturing site.
Equipment capabilities.
Operational layout.
Corporate headquarters.
Site Address.
50. Type II DMF
It includes information about all the significant steps in manufacturing and control
of drug substance and intermediates
Manufacturing sections
• Quality control
Inputs
Intermediates
and In-process
Finished drug
substance
Raw
Materials
Packing
Materials
• Validations.
• Stability data.
• Impurities.
• Packaging and labelling
51. Type III DMF
It contains detailed information of the packaging material used. i.e.,
Intended use of the packing material
Composition of the packing material.
Name of the suppliers.
Specifications.
Toxicological data on the packing material
Type IV DMF
• Excipients used in the manufacture of the product.
• Compendia excipients usually not reviewed so DMF is not required
52. Differences between the Application
(Dossier) and DMF
Sr.N
o
APPLICATION (DOSSIER) DMF
1 Must be filed by applicant Not mandatory to file DMF
2 Comes under regulatory status No such regulations
3 Each applications and their
supplements are entered in
common database
DMF’s are entered in separate
database as per the type
4 Submitted to intended review
division
Submitted to Regulatory body
5 Review procedure is different than
that of DMF
Reviewed only when referenced
with NDA/ ANDA applications
6 Approval timeline is there No approval timeline
53. DMF Filing System
Step 1
•Applicants file DMF
Step 2
•Submitted to Regulatory Body
Step 3
•Information in DMF is checked (Not Reviewed) and entered into DMF
database
Step 4
•DMF number will be assign and acknowledgement letter will be sent to
DMF holder along with reminder of obligations
54. DMF Reviewing System
Step
1
•Applicant file NDA or AND
Step
2
•Submit dossier and quotes DMF number as a supportive
documents for drug substance
Step
3
•Applicant will send letter of Authorization (LOA)
Step
4
•Upon receiving LOA DMF will be taken for Review
55. Important points to be noted in DMF
Holder: The person who submits a DMF.
Agent: The person or company who represents the DMF holder.
Applicant: The person or company who use the DMF for referencing in
the NDA or ANDA submission.
Agent will be appointed by the DMF holder to file DMF and to
communicate with the regulatory body.
Major contents of DMF are, Transmittal letter, Administrative
information of DMF holder, Technical information of the product.
Reason to file DMF: DMF filed for API’s which acts as supportive
document while submitting NDA or ANDA.
56. Obligations of DMF Holder
Should submit any changes as amendments.
Should notify regulatory body of change in holder name or address.
Should notify regulatory body of change in agent or representative.
Issue LOA to each applicant who intends to use that API.
Should submit annual report to regulatory body on the anniversary date of
DMF filing.
Symbols used in finding the status of DMF
“A” : Active, (DMF is acceptable and up to date)
“I” : Inactive
“N” : Not assigned DMF number
“P” : Pending filing review
57. DMF for OTC drugs and compendia excipients are never reviewed.
DMF cannot be registered or approved, it just entered in DMF database.
Letter of Authorization (LOA) shall be send by DMF holder to regulatory
body (2 copies) and NDA/ANDA applicant (1 copy).
DMF number will be assigned only when the regulatory body receives 2
copies of DMF along with the cover letter.
If any deficiencies found in DMF it shall be communicated with the
holder and the applicant will be just notified.
DMF shall be registered immediately but not reviewed.
58. Regulatory body will issue termination letter to DMF holder when there is
no communication for 3 consecutive years (i.e., no annual report) regarding
the DMF.
If annual report is not send, it causes delay in the review process of the
filed NDA and ANDA.
Regulatory body shall send a reminder letter called overdue notice letter
(ONL) to DMF holder, if there is no response from the holder within 90
days, one copy will be send to federal center and the other will be
destroyed.
Now a days DMF filing also become electronic submission and can
convert existing Paper MF’s to eCTD
59. COMMON TECHNICAL DOCUMENT (CTD)
It is an essential document to be submitted to regulatory body as a supportive list of leaflets
attached with the registration applications for pharmaceuticals to get market authorization.
Mainly CTD tells about the format for the data.
1. The Common Technical Document (CTD) guidance’s have been developed for Japan,
European Union and United States.
2. Most countries have adopted the CTD format. Hence, CDSCO has also decided to adopt
CTD format for technical requirements for registration of pharmaceutical products for
human use.
3. This guidance is developed by CDSCO based on:
a. The ICH Harmonized Tripartite Guideline on “Organization of the Common Technical
Document for the Registration of Pharmaceuticals for Human Use”. M4, Step 4 version
dated January 13, 2004, and
b. Drugs & Cosmetics Act 1940 and Rules made thereunder.
4. The CTD is only a format for submission of information to CDSCO.
60. CTD: OVERVIEW
The CTD is organized into five modules (Module 1, 2, 3, 4, and 5)
and a diagrammatic representation of organization of the CTD is
provided in Annexure I.
It is organized into:-
Module 1: General Information
Module 2: CTD summaries
Module 3: Quality
Module 4: Nonclinical study reports
Module 5: Clinical study reports
61. ELECTRONIC COMMON TECHNICAL
DOCUMENT (eCTD)
eCTD is electronic Common Technical Document, an electronic format
where the information and document is submitted to regulatory body
electronically by using a software. Some of the eCTD software are
Pharm ready, Edios etc.
Requirements of eCTD:
1. Copy and paste.
2. Verifying and printing documents.
3. Document Annotation.
4. Export of information to databases.
62. Sr.
No.
Common Technical
Document (CTD)
Electronic Common
Technical Document
(eCTD)
1 Paper submission Electronic (Using Software)
2 Tedious and Difficult Review process Faster review process
3 Bulk and Large documents XML files storage will be in GB
4 Cross references include CTD section
number
Cross references include hyperlink and
book mark
5 CTD navigation through TOC and Volumes eCTD navigation by XML backbone
6 Paper volume- A4 Layout shall be A4 or US letter size
7 Submitted in Binders or boxes Submitted on CD or DVD or e-mail or
Portal.
8 Compiled electronically with volumes, tabs
and slip sheets and then printed to paper.
Compiled electronically with documents in
folders
63. Regulated Market Non- Regulated Market
These countries have well-defined procedures for
marketing and distribution of pharmaceuticals both
for human and veterinary use. MAHs should file
applications to market their drugs with all the
supportive and required data.
eg. Major big countries with specific authorities /
monitoring bodies to look after health of its citizens
- US, JAPAN, AUSTRALIA, CANADA, INDIA,
Etc.
Regulated Pharma markets require submission of
dossier in CTD format which has to provide clinical
trial and bioequivalence studies.
Small to very countries which do not have any
specific authorities which controls the supply of
medicine.
One can consider newly formed countries, small
population countries and under developed countries.
AFRICAN countries, some Asian countries.
Being said since these countries do not have specific
monitoring authorities, they depend on other
regulated countries.